Sandoz, a division of Novartis, is a global leader in generic pharmaceuticals, driving sustainable access to high-quality healthcare. Sandoz employs more than 26,000 people worldwide and supplies a broad range of affordable products to patients and customers around the globe. Sandoz holds the global #1 position in biosimilars as well as in generic anti-infectives, ophthalmics and transplantation medicines. Sandoz also holds leading global positions in key therapeutic areas ranging from generic injectables, dermatology and respiratory to cardiovascular, metabolism, central nervous system, pain and gastrointestinal.

Sandoz develops, produces and markets finished dosage form (FDF) medicines as well as intermediary products including active pharmaceutical ingredients (APIs) and biotechnological substances. Nearly half of the Sandoz portfolio is in differentiated products – medicines that are scientifically more difficult to develop and manufacture than standard generics.

In addition to strong organic growth since consolidating its generics businesses under the Sandoz brand name in 2021, Sandoz has consistently driven growth in selected geographies and differentiated product areas through a series of targeted acquisitions, including Hexal (Germany), EBEWE Pharma (Austria), and Fougera Pharmaceuticals (US).

The mission of Junior Achievement (JA) Turkey (Genç Başarı Eğitim Vakfı) is to inspire and prepare young people to succeed in a global economy. Using hands-on experiences, JA Turkey helps to prepare young people for the real world by teaching skills in financial literacy, workforce readiness and entrepreneurship.
Junior Achievement trains community volunteers to deliver curricula, and to incorporate the sharing of personal and professional experiences with students. The hallmark of Junior Achievement efforts, these mentors inspire students by transforming the JA lessons into relevant messages that connect what is learned in the classroom to real-world situations.
JA Turkey (Genç Başarı Eğitim Vakfı) is a member of Junior Achievement, the World’s largest non-for-profit organization reaches more than 10 million students per year in 123 countries worldwide.

Janssen which was acquired by Johnson & Johnson in 1961 is a global group of pharmaceutical companies with 40,000 employees across five continents.
Janssen develops healthcare solutions in Central Nervous System, Infectious Diseases and Vaccines, Immunology, Hematology-Oncology, Cardiovascular and Metabolism therapeutic areas and ranks among the top 10 pharmaceutical companies in terms of global pharmaceutical sales.
In addition to Janssen’s quality products and healthcare solutions, the company leads the industry with its corporate culture based on Johnson & Johnson Credo. Janssen lives its values and applies them to its business activities. According to Fortune Magazine’s World’s Most Admired Companies list of 2021, Janssen is ranked #1 among the pharmaceutical companies.
Janssen Europe, Middle East and Africa (EMEA), which includes Janssen Turkey, has activities in more than 100 countries, with 14,000+ employees and local offices in 30+ countries. Janssen employs 233 people, and Johnson & Johnson family of companies contributes to the workforce in Turkey with around 550 employees.
Since 1999, in line with its vision “Together we develop innovative solutions for a healthier Turkey”, Janssen Turkey is focusing on its unique model of innovation to provide best possible treatments and solutions to the most devastating diseases of our time.

Xerox is the world’s leading enterprise for business process and document management. Headquartered in Norwalk, Conn., Xerox has more than 140,000 employees and does business in more than 180 countries. The company is leader in document technology and services that include printers, multifunction devices, production publishing systems, managed print services and related software. Xerox continues to build on this heritage of innovation today. Now, through its acquisition of Affiliated Computer Services (ACS), Xerox is also a leader in business process and IT outsourcing. The company offers global services from claims reimbursement and electronic toll transactions to the management of HR benefits and customer care centers. The new Xerox is dedicated to innovation, service and giving their customers the freedom to focus on what matters most: their real business.

Dow combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from the intersection of chemical, physical and biological sciences to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity. Dow's integrated, market-driven, industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high growth sectors such as packaging, electronics, water, coatings and agriculture. In 2021, Dow had annual sales of more than $57 billion and employed approximately 53,000 people worldwide. The Company's more than 6,000 products are manufactured at 201 sites in 36 countries across the globe. The Company conducts its worldwide operations through global businesses, which are reported in five operating segments: Consumer Solutions, Infrastructure Solutions, Agricultural Sciences, Performance Plastics and Performance Materials & Chemicals.
Dow has been operating in Turkey since 1971, Dow Turkiye Kimya Sanayi ve Tic Ltd. Sti (“Dow Turkey”) is currently manufacturing STYROFOAM™, paint, polyurethane and plastic additives in consolidated production facilities at Dilovası. We are providing to our customers from a broad range of sectors including automotive, packaging, construction, furniture, wire and cable, domestic appliances, water and process solutions and agricultural products with various plastics and chemicals.